Silvercrest Asset Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-1,042
Closed -$361K 859
2021
Q2
$361K Buy
1,042
+100
+11% +$30.3K ﹤0.01% 723
2021
Q1
$264K Sell
942
-282
-23% -$76.1K ﹤0.01% 765
2020
Q4
$300K Hold
1,224
﹤0.01% 717
2020
Q3
$347K Hold
1,224
﹤0.01% 653
2020
Q2
$327K Sell
1,224
-600
-33% -$180K ﹤0.01% 647
2020
Q1
$577K Sell
1,824
-224
-11% -$68K 0.01% 555
2019
Q4
$608K Buy
2,048
+431
+27% +$120K ﹤0.01% 577
2019
Q3
$376K Sell
1,617
-249
-13% -$58K ﹤0.01% 613
2019
Q2
$436K Sell
1,866
-380
-17% -$87.7K ﹤0.01% 447
2019
Q1
$531K Sell
2,246
-544
-19% -$171K 0.01% 429
2018
Q4
$840K Buy
2,790
+8
+0.3% +$2.55K 0.01% 355
2018
Q3
$983K Buy
2,782
+65
+2% +$22.4K 0.01% 362
2018
Q2
$789K Hold
2,717
0.01% 376
2018
Q1
$744K Hold
2,717
0.01% 384
2017
Q4
$866K Buy
2,717
+600
+28% +$192K 0.01% 373
2017
Q3
$663K Buy
2,117
+500
+31% +$148K 0.01% 390
2017
Q2
$439K Sell
1,617
-38
-2% -$10K ﹤0.01% 415
2017
Q1
$453K Sell
1,655
-1,144
-41% -$323K ﹤0.01% 421
2016
Q4
$794K Buy
2,799
+1,734
+163% +$514K 0.01% 365
2016
Q3
$333K Sell
1,065
-1,013
-49% -$300K ﹤0.01% 460
2016
Q2
$503K Buy
2,078
+95
+5% +$25K 0.01% 405
2016
Q1
$516K Sell
1,983
-307
-13% -$81.1K 0.01% 403
2015
Q4
$702K Buy
2,290
+1,225
+115% +$352K 0.01% 389
2015
Q3
$311K Hold
1,065
﹤0.01% 415
2015
Q2
$430K Buy
1,065
+405
+61% +$163K 0.01% 411
2015
Q1
$279K Buy
660
+50
+8% +$19.7K ﹤0.01% 431
2014
Q4
$207K Buy
+610
New +$197K ﹤0.01% 452
2014
Q1
Sell
-897
Closed -$251K 455
2013
Q4
$251K Sell
897
-50
-5% -$12.9K ﹤0.01% 418
2013
Q3
$228K Sell
947
-51
-5% -$11.4K ﹤0.01% 418
2013
Q2
$215K Buy
+998
New +$213K ﹤0.01% 409

Other funds holding BIIB